Interestingly, the therapy that depletes circulating asparagine in the blood using L-asparaginase is a universal therapy used in pediatric acute lymphoblastic leukemia (ALL) patients [31] (Figure 2). Here, ASPG is linked to acute lymphoblastic leukemia.